EP0808101A1 - Antimicrobic composition and its use - Google Patents

Antimicrobic composition and its use

Info

Publication number
EP0808101A1
EP0808101A1 EP96901371A EP96901371A EP0808101A1 EP 0808101 A1 EP0808101 A1 EP 0808101A1 EP 96901371 A EP96901371 A EP 96901371A EP 96901371 A EP96901371 A EP 96901371A EP 0808101 A1 EP0808101 A1 EP 0808101A1
Authority
EP
European Patent Office
Prior art keywords
acid
ester
composition according
weight
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96901371A
Other languages
German (de)
French (fr)
Inventor
Thomas Ahlnäs
Arthur MÜLLER
Sven-Olof Malmqvist
Timo LÖFGREN
Terttu Inkeri Ollikainen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kemira Chemicals Oy
Original Assignee
Kemira Chemicals Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemira Chemicals Oy filed Critical Kemira Chemicals Oy
Publication of EP0808101A1 publication Critical patent/EP0808101A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463Organic compounds; Microorganisms; Enzymes
    • A23L3/3481Organic compounds containing oxygen
    • A23L3/3508Organic compounds containing oxygen containing carboxyl groups
    • A23L3/3517Carboxylic acid esters
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/10Aromatic or araliphatic carboxylic acids, or thio analogues thereof; Derivatives thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/36Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
    • A01N37/38Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system
    • A01N37/40Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system having at least one carboxylic group or a thio analogue, or a derivative thereof, and one oxygen or sulfur atom attached to the same aromatic ring system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K30/00Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K30/00Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs
    • A23K30/10Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs of green fodder
    • A23K30/15Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs of green fodder using chemicals or microorganisms for ensilaging

Definitions

  • the invention is related to an antimicrobic composition and its use as a substance inhibiting the growth of detrimental microbes.
  • mixtures of organic acids particularly propionic acid and formic acid, or mixtures of organic acids and their ammonium salts, or salts of organic acids are used to prevent Salmonella in poultry forage.
  • the products are either solutions or solids.
  • the publication WO 92/21239 discloses an antimicrobic composition against, e.g., Salmonella, containing a polyunsaturated C 5 -C ⁇ 4 monocarboxylic acid, such as sorbic acid or its derivative, together with a substituted or an unsubstituted aromatic carboxylic acid, such as benzoic acid or its salt or ester.
  • the compositions may also contain organic or inorganic acids. Formic acid is not presented among the numerous acids listed in the publication.
  • Esters of parahydroxylbenzoic acid such as propylparaben, possibly together with butylated hydroxyanisole, are known to have an inhibiting effect on the growth of Salmonella (Proc. Int. Symp. Food Microbiol., 1 1th Meeting 1980, 377-84 (1981); J. Food Prot. (1980), 43(3), 191-4).
  • compositions containing C C 4 monocarboxylic acid and esters of unsubstituted or substituted benzoic acid are effective in preventing Salmonella and other detrimental microbes and inhibiting the growth thereof.
  • the antimicrobic composition according to the invention comprises a first antimicrobic component consisting of a first subcomponent a) which is an unsubstituted or substituted C]-C monocarboxylic acid.
  • the preferred amount is about 60-98 weight-% of the weight of the anitimicrobial component.
  • the unsubstituted or substituted C C 4 monocarboxylic acid is an acid selected from: formic acid, acetic acid, propionic acid, n-butyric acid, isobutyric acid, glycolic acid, lactic acid, hydroxybutyric acid, pyruvic acid, acetacetic acid, and a mixture thereof, preferably formic acid, acetic acid, propionic acid, lactic acid or a mixture thereof, most preferably formic acid or a mixture of formic acid and propionic acid.
  • the antimicrobic composition according to the invention comprises an antimicrobic component consisting of a second component which is an ester of an unsubstituted or substituted benzoic acid.
  • the antimicrobic component preferably contains about 1-20 weight-%, and preferably about 2-10 weight-% of an ester of unsubstituted or substituted benzoic acid.
  • the ester of the unsubstituted or the substituted benzoic acid is selected from esters of an unsubstituted benzoic acid and from those of a benzoic acid substituted with one or more alkyls, halogens, nitros, hydroxies, and/or aminos.
  • Especially preferred esters comprise esters of benzoic acid or those of p-hydroxybenzoic acid.
  • the ester of the unsubstituted or the substituted benzoic acid is the ester of the unsubstituted or substituted benzoic acid and an alcohol which is selected from: benzoic alcohol, methanol, ethanol, n-propanol, isopropanol, n-butyl alcohol, and isobutyl alcohol.
  • Especially preferred ester- forming alcohols include methanol, ethanol, n-propanol, and isopropanol.
  • Alcohols containing several hydroxyl groups that are viable for the ester of benzoic acid of the invention include, e.g., glycols, such as 1,2-propanediol, and triols, such as glycerol.
  • esters include methyl benzoate, ethyl benzoate, n-propyl benzoate. isopropyl benzoate, methyl-p-hydroxylic benzoate, ethyl-p-hydroxylic benzoate, n-propyl-p-hydroxylic benzoate, isopropyl-p-hydroxylic benzoate, and butyl-p-hydroxylic benzoate.
  • the advantageous embodiments of the invention thus contain activators that accelerate the decomposition of the ester. Tests have also indicated that compositions that catalyze the decomposition of esters, can also decompose carboxylic acid, formic acid in particular.
  • Typical activators include mineral acids, such as sulphuric acid, hydrochloric acid, nitric acid, and phosphoric acid or a mixture thereof. Regarding mineral acids, hydrochloric acid is a stronger catalyser than nitric acid.
  • the antimicrobic component of the composition according to the invention also comprises about 0.02-20 weight-%, preferably about 0.5-10 weight-% of the ester of C]-C 4 monocarboxylic acid that acts synergistically with the ester of the unsubstituted or the substituted benzoic acid, with C r C 4 alcohol.
  • Typical such esters include methylester, ethylester or propylester of formic acid, acetic acid or propionic acid. These substances are preferably obtained when C C-, alcohol, preferably propanol, is added to the composition in situ.
  • the antimicrobic component may contain other compositions that improve the preservation power, such as C 4 -C carboxylic acids, such as free benzoic acid, isobutyric acid or octanic acid, or corresponding alcohols; monoglycerides of C 8 -C 16 carboxylic acids or other bactericidal or bacteriostatic surface-active compositions, dicarboxylic acids, such as oxalic acid, malonic acid, succinic acid, adipic acid, pimelic acid, suberic acid.
  • C 4 -C carboxylic acids such as free benzoic acid, isobutyric acid or octanic acid, or corresponding alcohols
  • monoglycerides of C 8 -C 16 carboxylic acids or other bactericidal or bacteriostatic surface-active compositions dicarboxylic acids, such as oxalic acid, malonic acid, succinic acid, adipic acid, pimelic acid, suberic acid.
  • polykarboxylic acids such as polyacrylic acid, or copolymeric acids formed between unsaturated compounds that are polymerised with acrylic acid and polyacrylic acid
  • hydroxycarboxylic acids, dicarboxylic acids or polycarboxylic acids such as sorbic acid, ascorbic acid, cinnamic acid, salicylic acid, tartaric acid or maleic acid
  • complexing agents such as EDTA, DTPA; or derivatives, such as salts or esters, of all the above-mentioned acids.
  • the mixture may, depending on the application of use, further contain salts affecting as preservatives, including salts of magnesium, zink and copper, compositions that adjust animal nutrients or the salt content of the mixture or that buffer its pH, including ammonium phosphate or potassium sulphate; imidiatzolindylurea, phenolic compositions and sulphonic acids, such as lignosulphonates, or aldehydes, such as formadehyde.
  • components acting as antioxidants such as butylated hydroxyanisole or hydroxytoluene, or esters of gallic acid can be added to the mixture.
  • compositions according to the invention can also contain other compounds that react with water in an acidly manner, such as organic or inorcanig acids or polyacids, or compounds that form acids in a solution.
  • the acids may also be in a partly neutralised form, such as ammonium salts, for instance.
  • the compositions that form acids include inorganic or organic salts or acid anhydrides that react in an acidly manner.
  • the freezing point of the antimicrobic liquid component of the composition according to the invention is a few degrees above freezing point if its CpC, acid content is high and the water content very low at the same time. By increasing the water content, the melting point can be lowered considerably when desired.
  • a preferred water content is about 1-30 weight-% and preferably about 5-20 weight-%.
  • the preservatives according to the invention are either in the form of a solution or in a solid form.
  • the advantages of the solid state include better security during transport, a slight smell, and an easy dispensing.
  • the composition comprises, in addition to the antimicrobic component, also a solid corpuscular carrier.
  • the weight ratio between the antimicrobic component and the corpuscular carrier is in the range of 1 : 10 - 10: 1, preferably in the range of 3:7 - 7:3.
  • the specific surface of the corpuscular carrier has to be large enough, preferably at least about 10, and more preferably at least about 100 m 2 /g.
  • the approximate particle size of the corpuscular carrier is preferably 0.01-20 mm. most preferably about 0.1-2 mm.
  • the corpuscular substance mentioned above is preferably selected from the following: inorganic corpuscular substances based on silicium dioxide and/or alumina, such as siliceous earth, moler earth, silicic acid, silica, alumina, bentonite, montmorrillonite, perlite, steatite, chlorite, expanded vermiculite, calcium silicate, sodium aluminium silicate, and zeolites, inorganic salts that dissolve sparingly in water and organic acids, and organic substances such as synthetic polymers, cellulose, cellulose derivatives, lignin and lignin derivatives.
  • inorganic corpuscular substances based on silicium dioxide and/or alumina such as siliceous earth, moler earth, silicic acid, silica, alumina, bentonite, montmorrillonite, perlite, steatite, chlorite, expanded vermiculite, calcium silicate, sodium aluminium silicate, and zeolites, inorganic salts
  • the solid composition according to the invention ranges from fairly dry to fairly moist.
  • the former is easy to dispense also in lower temperatures, the latter may cake together in temperatures lower than the melting point of the liquid phase but when the temperature is increased, it is again easy to process.
  • the processibility can be even improved by powdering with a fine solidifying agent or other powder.
  • the composition according to the invention comprises an antimicrobic substance that is preferably absorbed in the corpuscular substance.
  • Particularly good preservative fluids include those that are easy to handle by dispensing devices, such as granular mineral absorbents, including moler earth, and lumpy celluloses.
  • Solic compositions are thus prepared by absorbing a composition in liquid form as such in a large-area inorganic or organic absorbent, such as silica, clay mineral, or cellulose or mixtures thereof.
  • Solid compositions may also be prepared so that its liquid ingredients or liquid compositions of the ingredients are separately absorbed in similar or different absorbents, which are finally mixed together. At the same time, other possible solid ingredients may be added.
  • the composition according to a particularly preferred embodiment of the invention is in a solid particle-like form so that the mineral acids and other possible compositions that unstabilize formic acid or the ester of the unsubstituted or substituted benzoic acid are situated in different particles than the formic acid and the said benzoic acid esters.
  • the antimicrobic substance is absorbed in the first part of the corpuscular substance, and the substance that accelerates the hydrolysis of the ester of the unsubstituted or the substituted benzoic acid is absorbed in the second part of the corpuscular substance.
  • a particularly preferred embodiment of the antimicrobic composition according to the invention is obtained with a composition comprising: 1) an antimicrobic component comprising: a) about 50-99.8 weight-% of unsubstituted or substituted C C 4 monocarboxylic acid, b) about 0.2-30 weight-% of the unsubstituted or the substituted ester of benzoic acid, c) about 0-20 weight-% of a substance that causes a hydrolysis of the ester of the unsubstituted or the substituted benzoic acid, d) about 0-20 weight-% of the ester of C r C monocarboxylic acid with alcohol that acts synergistically with the ester of the unsubstituted or the substituted benzoic acid,
  • This preferred embodiment also comprises the advantageous components and parametric relations which are presented above separately.
  • the invention is related to the use of any of the compositions described above as a substance inhibiting the growth of hazardous microbes, such as .Salmonella, in forage material and forage products and the like.
  • the composition may also be used to preserve green forage or grain, to improve the hygiene of cattle sheds and the like, or to disinfect devices, equipment, and packages.
  • Example 2 A test was conducted as in the previous example but using another forage sample. The following results were obtained:
  • Example 3 SALMONELLA
  • the Salmonella infantis used in the test had originally been isolated from a chicken and cultivated in buffered peptone water.
  • sets of dilution were made in peptone water by using different amounts of preservatives.
  • the growth of bacteria was observed by a Bioscreen device (Labsystems, Finland). The device automatically measures, from the set of samples, the cloudiness that depicts bacterial growth as a function of time.
  • Figs. 1 acetic acid
  • 2 acetic acid with 2.5 weight-% of EB and 2.5 weight-% of propyl formate
  • composition weight fractions
  • both acids activate the decomposition of both the ester and the formic acid.
  • hydrochloric acid was used, a considerable amount of carbon monoxide gas had formed already during one week in an incubator, and the amount of benzoic acid was so large that some of it had crystallized.
  • This composition that is rich in hydrochloric acid is thus suitable to be used only when no preservation time is required of the product.
  • Example 4A The test of Example 4A was repeated so that propyl benzoate was used instead of ethyl benzoate.
  • the amount of propyl benzoate in the sample containing sulphuric acid was 1.68 weight fractions, and 0.14 weight fractions in the sample containing hydrochloric acid. Both solutions remained clear.
  • Liquid mixtures were absorbed in a solid absorbent according to the next table.
  • the obtained products were packed in impermeable bottles which were kept in increased temperatures.
  • the amount of carbon monoxide generated as a breakdown product of the formic acid was analyzed from the gas phase of the bottles by using gas chromatograph. The following results were obtained:
  • Damolin was the same as the one used in the previous example.
  • Zeothix 265 is a precipitated silicic acid (Huber Corporation).
  • the cellulose was commercial sheet cellulose which was used to make pieces of about 1mm x 1mm by shredding it first with a shredder to form strips, which were then fed in transversally and, finally, oversized pieces were screened out.
  • Mixture 7/1 was granular and easy to process.
  • Mixture 7/2 felt dry but did not flow as easily as the former mixture.
  • Mixture 7/3 was fine and dry, but vault-fo ⁇ ning, and thus more difficult to dispense.
  • Mixture 7/4 maintained its block-like form and remained relatively easy to process, even though it felt damp.
  • the hardness of its pieces could be further improved by powdering the mixture with small amounts of a salt-like substance which form a slightly soluble formiate such as calcium or magnesium formiates.
  • a salt-like substance which form a slightly soluble formiate
  • Such substances include, e.g., finely powdered calcium chloride, calcium carbonate, dolomite, and calcium sulphate.
  • 60 parts by weight of a granular absorbent was mixed with 40 parts by weight of a mixture of strong formic acid, sulphuric acid, and ethyl benzoate in a ratio of 85: 10:5.
  • Another mixture was made with a similar approximate composition by mixing together a) 90 parts by weight of a mixture containing 60 weight-% of the absorbent and 40 weight-% of a mixture of formic acid and ethyl benzoate in a ratio of 94.4:5.6. and b) 10 parts by weight of a mixture containing 40 weight-% of sulphuric acid and 60 weight-% of the absorbent.
  • compositions according to the following table were prepared:
  • FA(EB) a mixture with 93.9 parts by weight of formic acid and 4.1 parts by weight of ethyl benzoate, and 0.03 parts by weight of benzoic acid.

Abstract

The invention is related to an antimicrobic composition whose antimicrobic component contains: a) about 50-99.8 weight % of unsubstituted or substituted C1-C4 monocarboxylic acid, and b) about 0.2-30 weight % of the ester or unsubstituted or substituted benzoic acid. The composite of the carboxylic acid and the ester of benzoic acid yields better results than when using, e.g., benzoic acid. The composition according to the invention can also contain a carrier in particle form in which the said antimicrobic component has been absorbed.

Description

ANTIMICROBIC COMPOSITION AND ITS USE
The invention is related to an antimicrobic composition and its use as a substance inhibiting the growth of detrimental microbes.
One significant quality-improving factor in food stuffs and in beef cattle and poultry forage is that they are free from Salmonella, Listeria, E. coli and other bacteria which cause food poisoning. Abundant use of antibiotics in controlling bacteria is not recommended because it results in the growth of resistant bacterial populations. Therefore, it is desired to discover improved preservatives.
According to the publication Poultry International, July 1994, pp. 40-42, mixtures of organic acids, particularly propionic acid and formic acid, or mixtures of organic acids and their ammonium salts, or salts of organic acids are used to prevent Salmonella in poultry forage. The products are either solutions or solids.
The publication Applied and Environmental Microbiology, Aug. 1980, 352-357 discloses that benzoates and their derivatives have been widely used as antimicrobials. Their effect increases with increased acidity, implying that the free acid works as an active ingredient.
The effect of propionic acid, acetic acid, sorbic acid, and benzoic acid and mixtures thereof are known from mould control of moist feed grain (Poultry Science 60 ( 1981), 2182-2188).
The publication Food Microbiology, 5 (1988) : 3, pp. 135-139 explains that a composition containing 1 % acetic acid, 1 % lactic acid, maleic acid, tartaric acid, or citric acid, 0.05 % sorbic acid, 0.05 % benzoic acid, and 3.5 % salt, acts, in a salad whose pH is buffered to 4.8, as a bactericide with respect to Salmonella blockley, Escherichia coli, and Staphylococcus aureus, and is bacteriostatic with respect to Streptococcus Faecalis.
The publication WO 92/21239 discloses an antimicrobic composition against, e.g., Salmonella, containing a polyunsaturated C5-Cι4 monocarboxylic acid, such as sorbic acid or its derivative, together with a substituted or an unsubstituted aromatic carboxylic acid, such as benzoic acid or its salt or ester. The compositions may also contain organic or inorganic acids. Formic acid is not presented among the numerous acids listed in the publication.
The publication International Journal of Food Microbiology 22 (1994) : 2-3, pp. 127^140, explains that the composition of potassium sorbate and sodium benzoate slows down or inhibits the growth of Salmonella in milk or cheese when its pH is regulated with propionic acid.
Esters of parahydroxylbenzoic acid, such as propylparaben, possibly together with butylated hydroxyanisole, are known to have an inhibiting effect on the growth of Salmonella (Proc. Int. Symp. Food Microbiol., 1 1th Meeting 1980, 377-84 (1981); J. Food Prot. (1980), 43(3), 191-4).
These prior art antimicrobic compositions have the disadvantage that when benzoic acid is used, its migration to microbe cells is unsatisfactory. On the other hand, when an ester of benzoic acid is used, its migration to microbe cells is satisfactory but it is not as effective as benzoic acid as an antimicrobial.
The problem of the publications described above has now been solved with the aid of a new antimicrobic composition which is mainly characterised in comprising an antimicrobic component that contains: a) about 50-99.8 weight-% of unsubstituted or substituted CrCA monocarboxylic acid, and b) about 0.2-30 weight-% of an ester of an unsubstituted or a substituted benzoic acid.
By using organic acid and an ester of benzoic acid together, a mixture is provided which penetrates microbe cells and forms an effective antimicrobic benzoic acid in the microbe cells. The present invention is related to compositions according to this principle in particular.
Thus it has been discovered that compositions containing C C4 monocarboxylic acid and esters of unsubstituted or substituted benzoic acid are effective in preventing Salmonella and other detrimental microbes and inhibiting the growth thereof.
The antimicrobic composition according to the invention comprises a first antimicrobic component consisting of a first subcomponent a) which is an unsubstituted or substituted C]-C monocarboxylic acid. The preferred amount is about 60-98 weight-% of the weight of the anitimicrobial component. According to one embodiment, the unsubstituted or substituted C C4 monocarboxylic acid is an acid selected from: formic acid, acetic acid, propionic acid, n-butyric acid, isobutyric acid, glycolic acid, lactic acid, hydroxybutyric acid, pyruvic acid, acetacetic acid, and a mixture thereof, preferably formic acid, acetic acid, propionic acid, lactic acid or a mixture thereof, most preferably formic acid or a mixture of formic acid and propionic acid.
The antimicrobic composition according to the invention comprises an antimicrobic component consisting of a second component which is an ester of an unsubstituted or substituted benzoic acid. The antimicrobic component preferably contains about 1-20 weight-%, and preferably about 2-10 weight-% of an ester of unsubstituted or substituted benzoic acid. According to one preferred embodiment, the ester of the unsubstituted or the substituted benzoic acid is selected from esters of an unsubstituted benzoic acid and from those of a benzoic acid substituted with one or more alkyls, halogens, nitros, hydroxies, and/or aminos. Especially preferred esters comprise esters of benzoic acid or those of p-hydroxybenzoic acid.
According to one embodiment, the ester of the unsubstituted or the substituted benzoic acid is the ester of the unsubstituted or substituted benzoic acid and an alcohol which is selected from: benzoic alcohol, methanol, ethanol, n-propanol, isopropanol, n-butyl alcohol, and isobutyl alcohol. Especially preferred ester- forming alcohols include methanol, ethanol, n-propanol, and isopropanol.
Alcohols containing several hydroxyl groups that are viable for the ester of benzoic acid of the invention include, e.g., glycols, such as 1,2-propanediol, and triols, such as glycerol.
Particularly preferred esters include methyl benzoate, ethyl benzoate, n-propyl benzoate. isopropyl benzoate, methyl-p-hydroxylic benzoate, ethyl-p-hydroxylic benzoate, n-propyl-p-hydroxylic benzoate, isopropyl-p-hydroxylic benzoate, and butyl-p-hydroxylic benzoate.
The results of a laboratory test carried out indicate that the effect of the mixtures of carboxylic aciάVbenzoic acid esters according to the invention is at its best if the stability of the esters against hydrolysis has been suitably lowered. It has been discovered in particular that the restarting of the growth of Salmonella after the treatment has been decreased in this case. Migration in forage material and through the cell walls of bacteria is probably strongest when the ester form is prevailing but the correctly-timed decomposition of esters and the resulting benzoic acid generated in situ in the object of use might be significant with respect to the effect of the bacterium.
It is important that, if in addition to said - monocarboxylic acid component, another substance that accelerates the hydrolysis of the ester of the unsubstituted or the substituted benzoic acid is used. The preferred content of this substance is 0.2- 20 weight-% of the weight of the antimicrobic component. A preferable content is 3-15 weight-%.
The advantageous embodiments of the invention thus contain activators that accelerate the decomposition of the ester. Tests have also indicated that compositions that catalyze the decomposition of esters, can also decompose carboxylic acid, formic acid in particular. Typical activators include mineral acids, such as sulphuric acid, hydrochloric acid, nitric acid, and phosphoric acid or a mixture thereof. Regarding mineral acids, hydrochloric acid is a stronger catalyser than nitric acid.
According to one embodiment, the antimicrobic component of the composition according to the invention also comprises about 0.02-20 weight-%, preferably about 0.5-10 weight-% of the ester of C]-C4 monocarboxylic acid that acts synergistically with the ester of the unsubstituted or the substituted benzoic acid, with CrC4 alcohol. Typical such esters include methylester, ethylester or propylester of formic acid, acetic acid or propionic acid. These substances are preferably obtained when C C-, alcohol, preferably propanol, is added to the composition in situ.
In addition to the above-mentioned ingredients, the antimicrobic component may contain other compositions that improve the preservation power, such as C4-C carboxylic acids, such as free benzoic acid, isobutyric acid or octanic acid, or corresponding alcohols; monoglycerides of C8-C16 carboxylic acids or other bactericidal or bacteriostatic surface-active compositions, dicarboxylic acids, such as oxalic acid, malonic acid, succinic acid, adipic acid, pimelic acid, suberic acid. fumaric acid, or maleic acid; polykarboxylic acids, such as polyacrylic acid, or copolymeric acids formed between unsaturated compounds that are polymerised with acrylic acid and polyacrylic acid; hydroxycarboxylic acids, dicarboxylic acids or polycarboxylic acids, such as sorbic acid, ascorbic acid, cinnamic acid, salicylic acid, tartaric acid or maleic acid; complexing agents, such as EDTA, DTPA; or derivatives, such as salts or esters, of all the above-mentioned acids. The mixture may, depending on the application of use, further contain salts affecting as preservatives, including salts of magnesium, zink and copper, compositions that adjust animal nutrients or the salt content of the mixture or that buffer its pH, including ammonium phosphate or potassium sulphate; imidiatzolindylurea, phenolic compositions and sulphonic acids, such as lignosulphonates, or aldehydes, such as formadehyde. Furthermore, components acting as antioxidants, such as butylated hydroxyanisole or hydroxytoluene, or esters of gallic acid can be added to the mixture.
In addition to C C4 monocarboxylic acids, the compositions according to the invention can also contain other compounds that react with water in an acidly manner, such as organic or inorcanig acids or polyacids, or compounds that form acids in a solution. The acids may also be in a partly neutralised form, such as ammonium salts, for instance. The compositions that form acids include inorganic or organic salts or acid anhydrides that react in an acidly manner.
Since even relatively small amounts of water decrease and, correspondingly, activators increase the decomposition of both esters and formic acid, the properties of the mixture can be modified so that a suitable level of activity and a storage stability sufficient for each application are achieved. The freezing point of the antimicrobic liquid component of the composition according to the invention is a few degrees above freezing point if its CpC, acid content is high and the water content very low at the same time. By increasing the water content, the melting point can be lowered considerably when desired. A preferred water content is about 1-30 weight-% and preferably about 5-20 weight-%.
In conventional temperatures, the preservatives according to the invention are either in the form of a solution or in a solid form. The advantages of the solid state include better security during transport, a slight smell, and an easy dispensing. According to a preferred embodiment of the invention, the composition comprises, in addition to the antimicrobic component, also a solid corpuscular carrier. In this case, it is advantageous if the weight ratio between the antimicrobic component and the corpuscular carrier is in the range of 1 : 10 - 10: 1, preferably in the range of 3:7 - 7:3. Because the issue often is about absorbing the antimicrobic liquid component on the corpuscular carrier, the specific surface of the corpuscular carrier has to be large enough, preferably at least about 10, and more preferably at least about 100 m2/g. The approximate particle size of the corpuscular carrier is preferably 0.01-20 mm. most preferably about 0.1-2 mm.
The corpuscular substance mentioned above is preferably selected from the following: inorganic corpuscular substances based on silicium dioxide and/or alumina, such as siliceous earth, moler earth, silicic acid, silica, alumina, bentonite, montmorrillonite, perlite, steatite, chlorite, expanded vermiculite, calcium silicate, sodium aluminium silicate, and zeolites, inorganic salts that dissolve sparingly in water and organic acids, and organic substances such as synthetic polymers, cellulose, cellulose derivatives, lignin and lignin derivatives.
The solid composition according to the invention ranges from fairly dry to fairly moist. The former is easy to dispense also in lower temperatures, the latter may cake together in temperatures lower than the melting point of the liquid phase but when the temperature is increased, it is again easy to process. The processibility can be even improved by powdering with a fine solidifying agent or other powder.
As already mentioned before, the composition according to the invention comprises an antimicrobic substance that is preferably absorbed in the corpuscular substance. Particularly good preservative fluids include those that are easy to handle by dispensing devices, such as granular mineral absorbents, including moler earth, and lumpy celluloses.
Solic compositions are thus prepared by absorbing a composition in liquid form as such in a large-area inorganic or organic absorbent, such as silica, clay mineral, or cellulose or mixtures thereof. Solid compositions may also be prepared so that its liquid ingredients or liquid compositions of the ingredients are separately absorbed in similar or different absorbents, which are finally mixed together. At the same time, other possible solid ingredients may be added. The composition according to a particularly preferred embodiment of the invention is in a solid particle-like form so that the mineral acids and other possible compositions that unstabilize formic acid or the ester of the unsubstituted or substituted benzoic acid are situated in different particles than the formic acid and the said benzoic acid esters.
Thus the antimicrobic substance is absorbed in the first part of the corpuscular substance, and the substance that accelerates the hydrolysis of the ester of the unsubstituted or the substituted benzoic acid is absorbed in the second part of the corpuscular substance. A particularly preferred embodiment of the antimicrobic composition according to the invention is obtained with a composition comprising: 1) an antimicrobic component comprising: a) about 50-99.8 weight-% of unsubstituted or substituted C C4 monocarboxylic acid, b) about 0.2-30 weight-% of the unsubstituted or the substituted ester of benzoic acid, c) about 0-20 weight-% of a substance that causes a hydrolysis of the ester of the unsubstituted or the substituted benzoic acid, d) about 0-20 weight-% of the ester of CrC monocarboxylic acid with alcohol that acts synergistically with the ester of the unsubstituted or the substituted benzoic acid, e) about 0-30 weight-% of water, and 2) a solid corpuscular carrier, whereby the weight ratio between the antimicrobic component and the solid corpuscular substance is in the range of 1 : 10 - 10:0.
This preferred embodiment also comprises the advantageous components and parametric relations which are presented above separately.
Lastly, the invention is related to the use of any of the compositions described above as a substance inhibiting the growth of hazardous microbes, such as .Salmonella, in forage material and forage products and the like. In this case, it is possible to add the composition to the forage material or animal forage in the form of a processing material or an additive. The composition may also be used to preserve green forage or grain, to improve the hygiene of cattle sheds and the like, or to disinfect devices, equipment, and packages.
Some implementive and reference examples are described in the following, the sole purpose thereof being to illustrate the invention.
Example 1 FORAGE TEST
An inoculate of Salmonella infantis, 1500-3000 bacteria/g of forage, was evenly mixed with a commercial forage product for feeding chickens, including about 2/3 of grain, the rest being mainly fish meal and soya. The studied preservative was spread in the infected forage as evenly as possible in an amount corresponding to a dosage of 8 kg/t. Peptone water was measured into a control bottle. The cultures were kept in 1 litre Erlenmayer bottles sealed with aluminium foil in room temperature. 2 parallel samples of 10 g each were taken of the cultures each sampling day. Sets of dilution were made of the samples after an Ultra-Turrax mixing. 50 μl of the samples were spread from the dilution tubes on agar sheets on Petri dishes. The bacterial colonies formed after an incubation of 24 h/37° C were counted.
Example Preservative pH The time for the Salmonella to disappear
0d/42d (2 parallel determinations)
Comparison Peptone water 6.8/6.5 42 d, 42 d
Comparison Solution 1 *) 6.2/5.8 7 d, 7 d
Comparison 95% solution 1 6 6..00//55..88 55 dd,, 4422 dd
5% H2S04
Comparison 90% solution 1 55..99//55..88 77 dd,, 77 dd
10% H2SO4
Invention 85% solution 1 66..00//66..11 11 dd,, 22 dd
10% H2SO4
5% ethyl benzoate
*) 78 % formic acid, 2 % phosphoric acid, and 20 % water
Example 2 A test was conducted as in the previous example but using another forage sample. The following results were obtained:
Example Preservative pH The time for the Salmonella to disappear
(2 parallel determinations)
Comparison Peptone water 6.5 19 d, 30 d
Comparison Solution 1 *) 5.9 19 d, 19 d
Invention 85% solution 1 6.1 5 d, 5 d
10% HC1
5% ethyl benzoate
) 78% formic acid, 2 % phosphoric acid, and 20% water The examples show that the forage buffers the test solution so that no result is achieved in the preservative through decrease in pH.
Example 3 SALMONELLA The Salmonella infantis used in the test had originally been isolated from a chicken and cultivated in buffered peptone water. For the test, sets of dilution were made in peptone water by using different amounts of preservatives. The growth of bacteria was observed by a Bioscreen device (Labsystems, Finland). The device automatically measures, from the set of samples, the cloudiness that depicts bacterial growth as a function of time. The results are presented in Figs. 1 (acetic acid) and 2 (acetic acid with 2.5 weight-% of EB and 2.5 weight-% of propyl formate). It is discernible that the growth of Salmonella is inhibited when the acetic acid content is 0.5 weight-%, but when 5 weight-% of the 1 : 1 ester mixture of ethyl benzoate + propyl formiate according to the invention was mixed with the acetic acid, the growth could be inhibited even with 0.3 weight-% of preservative.
Example 4A THE EFFECT OF MINERAL ACID ON STABILITY
The effect of sulphuric acid and hydrochloric acid on the stability of liquid compositions was studied. About 10 g of each composition was weighed into 100 ml bottles which were tightly sealed and kept in an increased temperature of 45° C for 10 days to accelerate the reaction. Then the amount of carbon monoxide gas generated in the gas phase of the bottles during the decomposition of the formic acid and the amount of the/ ethyl benzoate left in the solution and that of the benzoic acid generated as its breakdown product were analyzed. The results are shown below:
H2S04 HC1
Composition (weight fractions)
Formic acid (99 %) 72.6 72.6 Sulphuric acid (37 %) 23.1 - Hydrochloric acid (37 %) - 23.1 Ethyl benzoate 4.3 4.3
After one week: Appearance a clear crysl solution
CO. ml/bottle *) a) 0.91 25.8 b) 0.91 26.0
Ethyl benzoate, % a) 0.90 0.08 b) 0.90 0.07 Benzoic acid, % a) 2.73 3.51 b) 2.71 3.38
*) a) and b) are parallel samples
It is discemable that both acids activate the decomposition of both the ester and the formic acid. When hydrochloric acid was used, a considerable amount of carbon monoxide gas had formed already during one week in an incubator, and the amount of benzoic acid was so large that some of it had crystallized. This composition that is rich in hydrochloric acid is thus suitable to be used only when no preservation time is required of the product.
Example 4B
The test of Example 4A was repeated so that propyl benzoate was used instead of ethyl benzoate. The amount of propyl benzoate in the sample containing sulphuric acid was 1.68 weight fractions, and 0.14 weight fractions in the sample containing hydrochloric acid. Both solutions remained clear.
Example 5 STABILITY TEST ON A SOLID FORMULA:
STRONG FORMIC ACID AND AN 85 % FORMIC ACID
Liquid mixtures were absorbed in a solid absorbent according to the next table. The obtained products were packed in impermeable bottles which were kept in increased temperatures. The amount of carbon monoxide generated as a breakdown product of the formic acid was analyzed from the gas phase of the bottles by using gas chromatograph. The following results were obtained:
Composition, weight fractions A B C D E F
Solid absorbent 60 60 60 60 60 60
Formic acid (99 %) 40 - 34 - 38
Formic acid (85 %) - 40 - 34 - 38
H2S04, strong - - 4 4 - 2
Ethyl benzoate - - 2 2 2 2
The amount of the formed CO, ml/ 100 g 15 h in 60° C 0.2 0.1 3.8 0.3
36 h in 45° C - - - - 0. 1 0.1
The test indicates that with sulphuric acid present, the 99 % formic acid starts to dehydrate but aqueous formic acid is distinctly more stabile.
Example 6 PREPARATION OF SOLID ABSORBENT
59 weight fractions of granular absorbent called Damolin (Dansk Moler Industri A S) with a particle size of 0.2-0.6 mm was dispensed to the forward end of a screw conveyor during a certain period of time by using a feeding device. During the same period of time, 41 weight fractions of an acid mixture was fed on top of the absorbent on the screw conveyor by using a pump. The acid mixture contained:
Formic acid 68.0 weight-% Water 15.3 weight-%
Sulphuric acid 10.0 weight-%
Ethyl benzoate 5.0 weight-%
Phosphoric acid 1.7 weight-%
A fixed product was obtained which was easy to dispense. Example 7 PREPARATION OF SOLID ABSORBENTS The following fixed mixtures were made:
7/1 7/2 7/3 7/4 FA:EB 95:5 40 48 70 70 Damolin 60 48 30 - Zeothix 265 _ 4 _ _ Cellulose 30
FA = Formic acid EB = Ethyl benzoate
Damolin was the same as the one used in the previous example. Zeothix 265 is a precipitated silicic acid (Huber Corporation). The cellulose was commercial sheet cellulose which was used to make pieces of about 1mm x 1mm by shredding it first with a shredder to form strips, which were then fed in transversally and, finally, oversized pieces were screened out.
Mixture 7/1 was granular and easy to process. Mixture 7/2 felt dry but did not flow as easily as the former mixture. Mixture 7/3 was fine and dry, but vault-foπning, and thus more difficult to dispense. Mixture 7/4 maintained its block-like form and remained relatively easy to process, even though it felt damp. The hardness of its pieces could be further improved by powdering the mixture with small amounts of a salt-like substance which form a slightly soluble formiate such as calcium or magnesium formiates. Such substances include, e.g., finely powdered calcium chloride, calcium carbonate, dolomite, and calcium sulphate.
Example 8 MINERAL ACID IN THE SAME/A DIFFERENT GRANULE
60 parts by weight of a granular absorbent was mixed with 40 parts by weight of a mixture of strong formic acid, sulphuric acid, and ethyl benzoate in a ratio of 85: 10:5. Another mixture was made with a similar approximate composition by mixing together a) 90 parts by weight of a mixture containing 60 weight-% of the absorbent and 40 weight-% of a mixture of formic acid and ethyl benzoate in a ratio of 94.4:5.6. and b) 10 parts by weight of a mixture containing 40 weight-% of sulphuric acid and 60 weight-% of the absorbent. About 10 g samples of the mixtures were weighed into 100 ml bottles which were closed tightly and placed into an incubator at a temperature of 45° C for one week. The amount of carbon monoxide gas generated in the gas phase of the bottles in the breakdown reaction of formic acid was then analyzed. The results indicate that the stability of the product can be improved considerably by placing the mineral acid in a different granule:
Sample CO, ml/sample
Mineral acid in the same granule with formic acid and a benzoic acid ester 31.1
Mineral acid in a different granule 1.34
Example 9 PREPARATION OF A SY ERGISTIC ESTER MIXTURE
Compositions according to the following table were prepared:
Example 9/A 9/B 9/C 9/1
FA (EB) 95 85 85 75 H2S04 - - 10 10 Water - 10 - 10 Propanol 5 5 5 5
FA(EB) : a mixture with 93.9 parts by weight of formic acid and 4.1 parts by weight of ethyl benzoate, and 0.03 parts by weight of benzoic acid.
When the samples were analyzed, it could be perceived that none of the mixtures no longer contained propanol. Instead, propyl formiate had been formed:
9/A 9/B 9/C 9/D
Formic acid 87.5 75.4 76.5 66.7 Ethyl benzoate 4.1 3.6 3.0 2.4 Benzoic acid 0.03 0.03 0.5 0.6 Propanol 0.0 0.0 0.0 0.0 Propyl formiate 7.3 7.0 6.8 6.7
In a corresponding manner, it was possible to create propyl acetate in preservatives with acetic acid, and propyl propionate in solutions with propionic acid.

Claims

1. An antimicrobic composition, characterised in comprising an antimicrobic component containing a) about 50-99.8 weight-% of an unsubstituted or a substituted CpC-, monocarboxylic acid, and b) about 0.2-30 weight-% of the ester of an unsubstituted or a substituted benzoic acid.
2. A composition according to Claim 1, characterised in that the antimicrobic component comprises about 60-98 weight-% of an unsubstituted or a substituted C,- C monocarboxylic acid.
3. A composition according to Claim 1 or 2, characterised in that the unsubstituted or the substituted Cj-C4 monocarboxylic acid is an acid selected from the following: formic acid, acetic acid, propionic acid, n-butyric acid, isobutyric acid, glycolic acid, lactic acid, hydroxybutyric acid, pyruvic acid, acetacetic acid, and a mixture thereof, preferably formic acid, acetic acid, propionic acid, lactic acid, or a mixture thereof, preferably formic acid or a mixture of formic acid and propionic acid.
4. A composition according to Claim 1, 2 or 3, characterised in that the antimicrobic component comprises about 1-20 weight-%, preferably about 2-10 weight-% of the ester of an unstubstituted or a substituted benzoic acid.
5. A composition according to any of the preceding Claims, characterised in that the ester of the unsubstituted or the substituted benzoic acid is selected from the esters of a benzoic acid that is unsubstituted and a benzoic acid that is substituted by one or more alkyls. halogens, nitros, hydroxies, and/or aminos.
6. A composition according to Claim 5, characterised in that the the ester of the unsubstituted or the substituted benzoic acid is selected from the esters of benzoic acid or p-hydroxybenzoic acid.
7. A composition according to any of the preceding Claims, characterised in that the ester of the unsubstituted or the substituted benzoic acid is the ester of the unsubstituted or the substituted benzoic acid and an alcohol that is selected from the following: benzoic alcohol, methanol, ethanol, n-propanol. isopropyl alcohol, n- butyl alcohol, isobutyl alcohol.
8. A composition according to any of the preceding Claims, characterised in that the ester of the unsubstituted or the substituted benzoic acid is selected from the following: methyl benzoate, ethyl benzoate, n-propyl benzoate, iso propyl benzoate, methyl-p-hydroxybenzoate, ethyl-p-hydroxybenzoate, n-propyl-p-hydroxybenzoate, isopropyl-p-hydroxybenzoate, and butyl-p-hydroxybenzoate.
9. A composition according to any of the preceding Claims, characterised in that the antimicrobic component comprises c) about 0.2-20. preferably 3-15 weight-% of a substance that accelerates the hydrolysis of the ester of the unsubstituted or the substituted benzoic acid.
10. A composition according to Claim 9, characterised in that the substance that accelerates the hydrolysis of the ester of the benzoic acid is a mineral acid or a mineral acid mixture.
1 1. A composition according to any of the preceding Claims, characterised in that the antimicrobic component comprises d) about 0.02-20 weight-%, preferably about 0.5-10 weight-% of the ester of C,-C4 monocarboxylic acid with C C4 alcohol, affecting synergistically with the ester of the unsubstituted or the substituted benzoic acid.
12. A composition according to Claim 1 1, characterised in that the said ester of C,- C4 monocarboxylic acid with C]-C4 alcohol is the methyl ester, the ethyl ester or the propyl ester of formic acid, acetic acid or propionic acid.
13. A method for preparing the ester composition according to Claim 1 1 or 12, characterised in that the component d) is allowed to be formed in the composition by adding C]-C4 alcohol, preferably propanol, to it.
14. A composition according to any of the preceding Claims, characterised in that its antimicrobic component contains about 1-30 weight-%, preferably about 5-20 weight-% of water.
15. A composition according to any of the preceding Claims, characterised in comprising a fixed carrier in particle form.
16. A composition according to Claim 15, characterised in that the weight ratio between the antimicrobic component and the carrier in particle form is in the range of 1 : 10 - 10: 1, preferably in the range of 3:7 - 7:3.
17. A composition according to Claim 15 or 16, characterised in that the specific surface of the carrier in particle form is at least about 10, preferably at least 100 m2/g.
18. A composition according to Claim 15, 16 or 17, characterised in that the approximate particle size of the carrier in particle form is 0.01-20, preferably 0.1-2 mm.
19. A composition according to any of Claims 15-18, characterised in that the corpuscular substance is selected from the following: inorganic corpuscular substances based on silicium dioxide and/or aluminas, including siliceous earth, moler earth, silicic acid, silica, alumina, bentonite, montmorillonite, perlite. steatite, chlorite, expanded vermiculite, calcium silicate, and zeolites, inorganic salts slightly soluble in water and organic acids, and organic substances such as synthetic polymers, cellulose, cellulose derivatives, lignin, and ligneous derivatives.
20. A composition according to any of Claims 15-19, characterised in that the antimicrobic substance is absorbed in the corpuscular substance.
21. A composition according to any of Claims 15-20, characterised in that the antimicrobic substance is absorbed in the first part of the corpuscular substance and the substance that generates the hydrolysis of the ester of the unsubstituted or the substituted benzoic acid is absorbed in the second part of the corpuscular substance.
22. A composition according to any of the preceding Claims, characterised in comprising:
1 ) an antimicrobic component containing: a) about 50-99.8 weight-% of unsubstituted or substituted C C4 monocarboxylic acid, b) about 0.2-30 weight-% of unsubstituted or substituted ester of benzoic acid, c) about 0-20 weight-% of a substance generating the hydrolysis of the ester of the unsubstituted or the substituted benzoic acid, d) about 0-20 weight-% of the ester of C C4 monocarboxylic acid with alcohol, affecting synergistically with the ester of the unsubstituted or the substituted benzoic acid, e) about 0-30 weight-% of water, and 2) a fixed carrier in particle form so that the weight ratio between the antimicrobic component and the solid carrier in particle form substance is in the range of 1 : 10 - 10:0.
23. The use of the composition according to any of the preceding Claims as a substance that inhibits the growth of hazardous microbes, such as Salmonella, in forage materials and preparations, and similar materials.
24. The use according to Claim 23 as a processing matter or an additive of forage material or animal forage.
25. The use according to Claim 23 for preserving green forage or grain, for improving the hygiene of cattle sheds and similar premises, or for disinfecting devices, equipment, and packages.
EP96901371A 1995-02-06 1996-02-05 Antimicrobic composition and its use Withdrawn EP0808101A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI950512A FI100376B (en) 1995-02-06 1995-02-06 New preservative composition
FI950512 1995-02-06
PCT/FI1996/000066 WO1996024248A1 (en) 1995-02-06 1996-02-05 Antimicrobic composition and its use

Publications (1)

Publication Number Publication Date
EP0808101A1 true EP0808101A1 (en) 1997-11-26

Family

ID=8542767

Family Applications (2)

Application Number Title Priority Date Filing Date
EP96901370A Withdrawn EP0808100A1 (en) 1995-02-06 1996-02-05 New preservative composition
EP96901371A Withdrawn EP0808101A1 (en) 1995-02-06 1996-02-05 Antimicrobic composition and its use

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP96901370A Withdrawn EP0808100A1 (en) 1995-02-06 1996-02-05 New preservative composition

Country Status (6)

Country Link
EP (2) EP0808100A1 (en)
AU (2) AU4542296A (en)
EE (1) EE9700169A (en)
FI (1) FI100376B (en)
NO (1) NO304671B1 (en)
WO (2) WO1996024248A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6322807B1 (en) 1994-05-27 2001-11-27 Dsm N.V. Biocidal compositions
GB9618008D0 (en) * 1996-08-27 1996-10-09 Verdugt Bv Biocidal compositions
NL1004488C2 (en) * 1996-11-11 1998-05-14 Minotara Corp N V Aqueous food mainly based on an acid and / or derivatives thereof.
GB9807287D0 (en) * 1998-04-03 1998-06-03 Verdugt Bv Biocidal compositions
EP1036511A3 (en) * 1999-03-15 2001-08-29 Ralf M. Kern Method for preservation and composition for use therewith
FR2801791B1 (en) * 1999-12-03 2003-05-30 Elpronat COMPOSITION FOR ANIMALS CONTAINING METHYL SALICYLATE
FR2810547B1 (en) * 2000-06-22 2004-01-30 Pasteur Institut USE OF C2-C10 ACIDS FOR THE PREVENTION OF NEGATIVE GRAM BACTERIA INFECTIONS
US7727568B2 (en) 2003-06-05 2010-06-01 Purac Biochem B.V. Antimicrobial composition comprising a mixture of lactic acid or a derivative thereof and an inorganic acid
EP1483975A1 (en) * 2003-06-05 2004-12-08 PURAC Biochem BV Antimicrobial composition comprising a mixture of lactic acid or a derivative thereof and an inorganic acid
EP1973418B1 (en) * 2006-01-13 2016-05-18 DSM IP Assets B.V. Use of a nutraceutical composition in animal feed
WO2007142919A2 (en) * 2006-05-30 2007-12-13 The Dial Corporation Compositions having a high antiviral effeicacy
CA2654079A1 (en) 2006-06-02 2008-03-27 The Dial Corporation Method of inhibiting the transmission of influenza virus
HUE031547T2 (en) 2009-08-06 2017-07-28 Anitox Corp Water and feed preservative
MX2014006542A (en) * 2011-11-30 2014-07-09 Anitox Corp Antimicrobial mixture of aldehydes, organic acids and organic acid esters.
US11285122B2 (en) 2013-07-02 2022-03-29 Ecoplanet Environmental Llc Volatile organic compound formulations having antimicrobial activity
CN106414752A (en) 2013-07-02 2017-02-15 桉树脑有限责任公司 Volatile organic compound formulations having antimicrobial activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2507067C2 (en) * 1975-02-19 1984-10-11 Plate Bonn Gmbh, 5300 Bonn Process for the prevention of aerobic degradation processes in green fodder silages
FI63328C (en) * 1981-03-30 1983-06-10 Martti Emil Lampila ENSILERINGMEDELKOMPOSITION FOER ENSILERING AV GROENFODER OCH LIKNANDE
NZ240355A (en) * 1991-06-04 1994-09-27 Ecolab Inc Sanitising composition comprising sorbic and benzoic acids
FI95195C (en) * 1992-02-27 1996-01-10 Kemira Oy preservative Mixes
FI920886A (en) * 1992-02-27 1993-08-28 Kemira Oy KONSEVERINGSMEDEL FOER FAERSKFODER

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9624248A1 *

Also Published As

Publication number Publication date
FI100376B (en) 1997-11-28
NO973575D0 (en) 1997-08-04
WO1996024247A1 (en) 1996-08-15
EE9700169A (en) 1998-02-16
EP0808100A1 (en) 1997-11-26
NO304671B1 (en) 1999-02-01
NO973575L (en) 1997-08-04
AU4542296A (en) 1996-08-27
FI950512A (en) 1996-08-07
FI950512A0 (en) 1995-02-06
WO1996024248A1 (en) 1996-08-15
AU4542196A (en) 1996-08-27

Similar Documents

Publication Publication Date Title
WO1996024248A1 (en) Antimicrobic composition and its use
EP2121478B1 (en) Food preservation compositions and methods of use thereof
SIRAGUSA THE EFFECTIVENESS OF CARCASS DECONTAMINATION SYSTEMS FOR CONTROLLING THE PRESENCE OF PATHOGENS ON THE SURFACES OF MEAT ANIMAL CARCASSES 1
EP0926952B1 (en) An antimicrobial composition, a method for the preparation of same
CA2283802C (en) Propionic acid, ammonia, propanediol and water solutions and the use thereof
CA1131064A (en) Propionic acid on a carrier material as a preservative
CN1059454A (en) Long-lasting fungicide for composite feed
JPH05320017A (en) Composition having improved antibacteria property and method for suppressing propagation of micro-organism such as listeria bacteria by using said composition
US5547987A (en) Pathogen inhibitor for animal feeds
CN108794957A (en) A kind of Efficient antibacterial Perserving materials and preparation method thereof
WO2000035305A1 (en) Broad-range antibacterial composition
EP2294924B1 (en) Method for obtaining 1-monopropionine and its isomer 3-monopropionine as preserving agents for animal feed, grains and animal-origin flours
US4073889A (en) Method for preventing aerobic decomposition processes in fermentated fodder
CN105054217A (en) Compound food preservative
CN107156289A (en) A kind of fresh-keeping of vegetables bactericidal agent and preparation method thereof
US4079150A (en) Ensiling agent for fodder plants and a method of fermentating fodder plants
CN100353871C (en) Granular concave rod alcohol antistaling agent
JP4077145B2 (en) Agricultural and horticultural products
CN1284266A (en) Mildew preventing preservative and its preparation and use
CN1505934A (en) Grape preservative of chlorine dioxide
US8877272B2 (en) 1-monopropionine compound and its isomer 3-monopropionine as preserving agents for animal feed, grains and animal-origin meals
JP2005304507A (en) Method for retaining freshness of agricultural product/horticultural product
JP2003286120A (en) Method for preserving live fungus preparation of genus fusarium fungus
AU712872B2 (en) Ensiling composition
Ohyama et al. The effectiveness of two additives in preventing aerobic deterioration of maize silages after opening silo

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970826

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IE IT LI NL PT SE

17Q First examination report despatched

Effective date: 19991216

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000427